Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SprayDye: Ex Vivo Tumor Visualization Using Topically Applied Fluorescent Imaging Agents
NCT06292845Recruiting
- Sponsor
- Erasmus MC
- Start
- Jan 2024
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial in solid tumor, sponsored by Erasmus MC. Primary endpoint: Tumor-to-background ratio at 3 years. Started Jan 2024; status: recruiting.
02
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06292845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06292845.